Cell migration, proliferation, and EMT in the NSCLC cells with cotreatment of OPN and CSE/hypoxic condition in vivo, as well as the interaction of OPN and EMT in EGFR‐TKI‐resistant patients remain to be further studied. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.